Their findings suggest that IL-6 can stimulate pancreatic cancer cells to release Th2 cytokines, consequently fostering the generation of Th2 cells and indirectly facilitating immune evasion by tumor cells (40). This evidence concerns the gene IL6 and neoplasm.